Menu

Biocept, Inc. BIOC

Full chart Compare
Set alert

Price alert · BIOC

All alert types
0.43 +0.43

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $125.00KExpenses → Gross Loss: $2.58MExpenses → Selling, General & Admin: $23.24MExpenses → Research & Development: $6.16MExpenses → Other Expenses: $229.00KNet Loss → Expenses: $32.09MHealth Care, Patient Service → Revenue: $25.62MRevenue → Cost of Revenue: $25.86MDevelopment Services → Revenue: $240.00KKits And Specimen Collection Tubes → Revenue: $2.00KIncome Tax Benefit$125.00KNet Loss$32.09MCost of Revenue$28.44MExpenses$32.21MGross Loss$2.58MSelling, General & Admin$23.24MResearch & Development$6.16MOther Expenses$229.00KRevenue$25.86MHealth Care, Patient Service$25.62MDevelopment Services$240.00KKits And Specimen Collection Tubes$2.00K

Latest period ending Dec 31, 2022 · select a line to chart its full history

BIOC annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
25.86M61.25M27.46M5.53M3.25M
-2.58M23.48M6.12M-5.45M-6.80M
-31.98M-2.41M-15.47M-23.06M-24.26M
-32.09M-2.82M-17.81M-25.14M-24.57M
-56.70-5.70-45.00-366.90-2,703.00
BIOC annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
12.90M28.86M14.37M9.30M3.42M
30.87M60.42M47.45M17.73M8.75M
22.01M22.94M23.76M6.53M5.71M
12.11M12.67M12.23M2.54M1.63M
8.86M37.48M23.69M11.20M3.04M
BIOC annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-13.29M3.69M-19.79M-23.05M-22.36M
-807.00K-1.57M-867.00K-735.30K-145.25K
-1.87M12.38M25.72M29.66M23.78M
-807.00K-1.57M-867.00K-735.30K-145.25K
-15.97M14.50M5.07M5.88M1.28M